Malformations of cortical development (MCD) comprise a broad spectrum of developmental brain abnormalities. Patients presenting with MCDs often suffer from drug-resistant focal epilepsy, and some become candidates for epilepsy surgery. Their likelihood of achieving freedom from seizures, however, remains uncertain, and depends in a major part on the underlying pathology. Tissue samples obtained in epilepsy surgery form the basis of definite histopathological diagnosis; however, new molecular genetic methods have not yet been implemented in diagnostic processes for MCD cases. Furthermore, it has not been completely understood how the underlying pathology affects patients' outcomes after epilepsy surgery. We performed a systematic literature review of studies describing both histopathological and molecular genetic findings in MCD, along with studies on epilepsy surgery outcomes. We aimed to correlate the genetic causes with the underlying morphological abnormalities in focal cortical malformations and to stress the importance of the underlying biology for patient management and counseling. From the summarized findings of multiple authors, it is obvious that MCD may have a diverse genetic background despite a similar or even identical histopathological picture. Even though most of their molecular genetic findings converge on various levels of the PI3K/AKT/mTOR pathway, the exact mechanisms underlying MCD formation have not yet been completely described or indeed how this pathway generates a diverse range of histological abnormalities. Based on our findings, we therefore propose that all patients diagnosed and operated for drug-resistant epilepsy should have an integrated molecular and pathological diagnosis similar to the current practice in brain tumor diagnostic processes that might lead to more accurate diagnosis and effective stratification of patients undergoing epilepsy surgery.

2nd Faculty of Medicine Charles University Prague Czech Republic

2nd Faculty of Medicine Department of Paediatric Neurology Charles University and Motol University Hospital Prague Czech Republic

Department of Histopathology Great Ormond Street Hospital for Children NHS Foundation Trust London UK

Developmental Biology and Cancer Programme UCL GOS Institute of Child Health London UK

Komentář v

Brain Pathol. 2019 Jul;29(4):467-468. doi: 10.1111/bpa.12714. PubMed

Zobrazit více v PubMed

Adler S, Lorio S, Jacques TS, Benova B, Gunny R, Cross JH et al (2017) Towards in vivo focal cortical dysplasia phenotyping using quantitative MRI. Neuroimage Clin 15:95–105. PubMed PMC

Baldassari S, Picard F, Verbeek NE, van Kempen M, Brilstra EH, Lesca G et al (2018) The landscape of epilepsy‐related GATOR1 variants. Genet Med. PubMed PMC

Barba C, Jacques T, Kahane P, Polster T, Isnard J, Leijten FS et al (2013) Epilepsy surgery in neurofibromatosis type 1. Epilepsy Res 105:384–395. PubMed

Baulac S (2014) Genetics advances in autosomal dominant focal epilepsies: focus on DEPDC5. Prog Brain Res 213:123–139. PubMed

Baulac S, Ishida S, Marsan E, Miquel C, Biraben A, Nguyen D et al (2015) Familial focal epilepsy with focal cortical dysplasia due to DEPDC5 mutations. Ann Neurol 77:675–683. PubMed

Becker AJ, Urbach H, Scheffler B, Baden T, Normann S, Lahl R et al (2002) Focal cortical dysplasia of Taylor's balloon cell type: mutational analysis of the TSC1 gene indicates a pathogenic relationship to tuberous sclerosis. Ann Neurol 52:29–37. PubMed

Blumcke I, Aronica E, Miyata H, Sarnat HB, Thom M, Roessler K et al (2016) International recommendation for a comprehensive neuropathologic workup of epilepsy surgery brain tissue: a consensus Task Force report from the ILAE Commission on Diagnostic Methods. Epilepsia 57:348–358. PubMed

Blumcke I, Spreafico R, Haaker G, Coras R, Kobow K, Bien CG et al (2017) Histopathological findings in brain tissue obtained during epilepsy surgery. N Engl J Med 377:1648–1656. PubMed

Blumcke I, Thom M, Aronica E, Armstrong DD, Vinters HV, Palmini A et al (2011) The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission. Epilepsia 52:158–174. PubMed PMC

Conti V, Pantaleo M, Barba C, Baroni G, Mei D, Buccoliero AM et al (2015) Focal dysplasia of the cerebral cortex and infantile spasms associated with somatic 1q21.1‐q44 duplication including the AKT3 gene. Clin Genet 88:241–247. PubMed

D'Gama AM, Woodworth MB, Hossain AA, Bizzotto S, Hatem NE, LaCoursiere CM et al (2017) Somatic mutations activating the mTOR pathway in dorsal telencephalic progenitors cause a continuum of cortical dysplasias. Cell Rep 21:3754–3766. PubMed PMC

Eltze CM, Chong WK, Bhate S, Harding B, Neville BG, Cross JH (2005) Taylor‐type focal cortical dysplasia in infants: some MRI lesions almost disappear with maturation of myelination. Epilepsia 46:1988–1992. PubMed

Englot DJ, Breshears JD, Sun PP, Chang EF, Auguste KI (2013) Seizure outcomes after resective surgery for extra‐temporal lobe epilepsy in pediatric patients. J Neurosurg Pediatr 12:126–133. PubMed

Englot DJ, Rolston JD, Wang DD, Sun PP, Chang EF, Auguste KI (2013) Seizure outcomes after temporal lobectomy in pediatric patients. J Neurosurg Pediatr 12:134–141. PubMed

Fauser S, Essang C, Altenmuller DM, Staack AM, Steinhoff BJ, Strobl K et al (2015) Long‐term seizure outcome in 211 patients with focal cortical dysplasia. Epilepsia 56:66–76. PubMed

Goto J, Talos DM, Klein P, Qin W, Chekaluk YI, Anderl S et al (2011) Regulable neural progenitor‐specific Tsc1 loss yields giant cells with organellar dysfunction in a model of tuberous sclerosis complex. Proc Natl Acad Sci USA 108:E1070–E1079. PubMed PMC

Guerrini R, Dobyns WB (2014) Malformations of cortical development: clinical features and genetic causes. Lancet Neurol 13:710–726. PubMed PMC

Gumbinger C, Rohsbach CB, Schulze‐Bonhage A, Korinthenberg R, Zentner J, Häffner M et al (2009) Focal cortical dysplasia: a genotype–phenotype analysis of polymorphisms and mutations in the TSC genes. Epilepsia 50:1396–1408. PubMed

Harvey AS, Cross JH, Shinnar S, Mathern GW, Pediatric Epilepsy Surgery Survey Taskforce (2008) Defining the spectrum of international practice in pediatric epilepsy surgery patients. Epilepsia 49:146–155. PubMed

Hemb M, Velasco TR, Parnes MS, Wu JY, Lerner JT, Matsumoto JH et al (2010) Improved outcomes in pediatric epilepsy surgery: the UCLA experience, 1986‐2008. Neurology 74:1768–1775. PubMed PMC

Jahan R, Mischel PS, Curran JG, Peacock WJ, Shields DW, Vinters HV (1997) Bilateral neuropathologic changes in a child with hemimegalencephaly. Pediatr Neurol 17:344–349. PubMed

Jahodova A, Krsek P, Kyncl M, Jezdik P, Kudr M, Komarek V et al (2014) Distinctive MRI features of the epileptogenic zone in children with tuberous sclerosis. Eur J Radiol 83:703–709. PubMed

Jansen LA, Mirzaa GM, Ishak GE, O'Roak BJ, Hiatt JB, Roden WH et al (2015) PI3K/AKT pathway mutations cause a spectrum of brain malformations from megalencephaly to focal cortical dysplasia. Brain 138:1613–1628. PubMed PMC

Jansen LA, Mirzaa GM, Ishak GE, O'Roak BJ, Hiatt JB, Roden WH et al (2015) PI3K/AKT pathway mutations cause a spectrum of brain malformations from megalencephaly to focal cortical dysplasia. Brain 138:1613–1628. PubMed PMC

Jansen FE, van Huffelen AC, Algra A, van Nieuwenhuizen O (2007) Epilepsy surgery in tuberous sclerosis: a systematic review. Epilepsia 48:1477–1484. PubMed

Kabat J, Krol P (2012) Focal cortical dysplasia ‐ review. Pol J Radiol 77:35–43. PubMed PMC

Kobow K, Blumcke I (2014) Epigenetic mechanisms in epilepsy. Prog Brain Res 213:279–316. PubMed

Krsek P, Jahodova A, Kyncl M, Kudr M, Komarek V, Jezdik P et al (2013) Predictors of seizure‐free outcome after epilepsy surgery for pediatric tuberous sclerosis complex. Epilepsia 54:1913–1921. PubMed

Krsek P, Maton B, Jayakar P, Dean P, Korman B, Rey G et al (2009) Incomplete resection of focal cortical dysplasia is the main predictor of poor postsurgical outcome. Neurology 72:217–223. PubMed

Krsek P, Maton B, Korman B, Pacheco‐Jacome E, Jayakar P, Dunoyer C et al (2008) Different features of histopathological subtypes of pediatric focal cortical dysplasia. Ann Neurol 63:758–769. PubMed

Krsek P, Pieper T, Karlmeier A, Hildebrandt M, Kolodziejczyk D, Winkler P et al (2009) Different presurgical characteristics and seizure outcomes in children with focal cortical dysplasia type I or II. Epilepsia 50:125–137. PubMed

Kurian M, Korff CM, Ranza E, Bernasconi A, Lubbig A, Nangia S et al (2018) Focal cortical malformations in children with early infantile epilepsy and PCDH19 mutations: case report. Dev Med Child Neurol 60:100–105. PubMed

Lamberink HJ, Boshuisen K, van Rijen PC, Gosselaar PH, Braun KP (2015) Changing profiles of pediatric epilepsy surgery candidates over time: A nationwide single‐center experience from 1990 to 2011. Epilepsia 56:717–725. PubMed

Lassuthova P, Safka Brozkova D, Krutova M, Neupauerova J, Haberlova J, Mazanec R et al (2016) Improving diagnosis of inherited peripheral neuropathies through gene panel analysis. Orphanet J Rare Dis 11:118. PubMed PMC

Lee JH, Huynh M, Silhavy JL, Kim S, Dixon‐Salazar T, Heiberg A et al (2012) De novo somatic mutations in components of the PI3K‐AKT3‐mTOR pathway cause hemimegalencephaly. Nat Genet 44:941–945. PubMed PMC

Lemke JR, Riesch E, Scheurenbrand T, Schubach M, Wilhelm C, Steiner I et al (2012) Targeted next generation sequencing as a diagnostic tool in epileptic disorders. Epilepsia 53:1387–1398. PubMed

Leventer RJ, Jansen FE, Mandelstam SA, Ho A, Mohamed I, Sarnat HB et al (2014) Is focal cortical dysplasia sporadic? Family evidence for genetic susceptibility Epilepsia 55:e22–e26. PubMed

Leventer RJ, Scerri T, Marsh AP, Pope K, Gillies G, Maixner W et al (2015) Hemispheric cortical dysplasia secondary to a mosaic somatic mutation in MTOR. Neurology 84:2029–2032. PubMed PMC

Li MM, Datto M, Duncavage EJ, Kulkarni S, Lindeman NI, Roy S et al (2017) Standards and guidelines for the interpretation and reporting of sequence variants in cancer: a joint consensus recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists. J Mol Diagn 19:4–23. PubMed PMC

Lim JS, Gopalappa R, Kim SH, Ramakrishna S, Lee M, Kim WI et al (2017) Somatic mutations in TSC1 and TSC2 cause focal cortical dysplasia. Am J Hum Genet 100:454–472. PubMed PMC

Lim J, Kim W‐I, Kang H‐C, Kim S, Park A, Park E et al (2015) Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsy. Nat Med 21:395–400. PubMed

Lim JS, Lee JH (2016) Brain somatic mutations in MTOR leading to focal cortical dysplasia. BMB Rep 49:71–72. PubMed PMC

Louis DN, Perry A, Burger P, Ellison DW, Reifenberger G, von Deimling A et al (2014) International Society of Neuropathology–Haarlem consensus guidelines for nervous system tumor classification and grading. Brain Pathol 24:429–435. PubMed PMC

Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella‐Branger D, Cavenee WK et al (2016) The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol 131:803–820. PubMed

Madhavan D, Schaffer S, Yankovsky A, Arzimanoglou A, Renaldo F, Zaroff CM et al (2007) Surgical outcome in tuberous sclerosis complex: a multicenter survey. Epilepsia 48:1625–1628. PubMed

Majores M, Blümcke I, Urbach H, Meroni A, Hans V, Holthausen H et al (2005) Distinct allelic variants of TSC1 and TSC2 in epilepsy‐associated cortical malformations without balloon cells. J Neuropathol Exp Neurol 64:629–637. PubMed

Martin KR, Zhou W, Bowman MJ, Shih J, Au KS, Dittenhafer‐Reed KE et al (2017) The genomic landscape of tuberous sclerosis complex. Nat Commun 8:15816. PubMed PMC

Mirzaa GM, Campbell CD, Solovieff N, Goold CP, Jansen LA, Menon S et al (2016) Association of MTOR mutations with developmental brain disorders, including megalencephaly, focal cortical dysplasia, and pigmentary mosaicism. JAMA Neurol 73:836. PubMed PMC

Mirzaa GM, Campbell CD, Solovieff N, Goold CP, Jansen LA, Menon S et al (2016) Association of MTOR mutations with developmental brain disorders, including megalencephaly, focal cortical dysplasia, and pigmentary mosaicism. JAMA Neurol 73:836–845. PubMed PMC

Moller RS, Weckhuysen S, Chipaux M, Marsan E, Taly V, Bebin EM et al (2016) Germline and somatic mutations in the MTOR gene in focal cortical dysplasia and epilepsy. Neurol Genet 2:e118. PubMed PMC

Muhlebner A, Groppel G, Dressler A, Reiter‐Fink E, Kasprian G, Prayer D et al (2014) Epilepsy surgery in children and adolescents with malformations of cortical development–outcome and impact of the new ILAE classification on focal cortical dysplasia. Epilepsy Res 108:1652–1661. PubMed

Nakashima M, Saitsu H, Takei N, Tohyama J, Kato M, Kitaura H et al (2015) Somatic mutations in the MTOR gene cause focal cortical dysplasia type IIb. Ann Neurol 78:375–386. PubMed

Northrup H, Krueger DA, International Tuberous Sclerosis Complex Consensus G (2013) Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol 49:243–254. PubMed PMC

Poduri A, Evrony GD, Cai X, Elhosary PC, Beroukhim R, Lehtinen MK et al (2012) Somatic activation of AKT3 causes hemispheric developmental brain malformations. Neuron 74:41–48. PubMed PMC

Qin W, Chan JA, Vinters HV, Mathern GW, Franz DN, Taillon BE et al (2010) Analysis of TSC cortical tubers by deep sequencing of TSC1, TSC2 and KRAS demonstrates that small second‐hit mutations in these genes are rare events. Brain Pathol 20:1096–1105. PubMed PMC

Ribierre T, Deleuze C, Bacq A, Baldassari S, Marsan E, Chipaux M et al (2018) Second‐hit mosaic mutation in mTORC1 repressor DEPDC5 causes focal cortical dysplasia‐associated epilepsy. J Clin Investig 128:2452–2458. PubMed PMC

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier‐Foster J et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405–424. PubMed PMC

Ricos MG, Hodgson BL, Pippucci T, Saidin A, Ong YS, Heron SE et al (2016) Mutations in the mammalian target of rapamycin pathway regulators NPRL2 and NPRL3 cause focal epilepsy. Ann Neurol 79:120–131. PubMed

Scerri T, Riseley JR, Gillies G, Pope K, Burgess R, Mandelstam SA et al (2015) Familial cortical dysplasia type IIA caused by a germline mutation in DEPDC5. Ann Clin Transl Neurol 2:575–580. PubMed PMC

Scheffer IE, Heron SE, Regan BM, Mandelstam S, Crompton DE, Hodgson BL et al (2014) Mutations in mammalian target of rapamycin regulator DEPDC5 cause focal epilepsy with brain malformations. Ann Neurol 75:782–787. PubMed

van Scheppingen J, Iyer AM, Prabowo AS, Muhlebner A, Anink JJ, Scholl T et al (2016) Expression of microRNAs miR21, miR146a, and miR155 in tuberous sclerosis complex cortical tubers and their regulation in human astrocytes and SEGA‐derived cell cultures. Glia 64:1066–1082. PubMed

Sim JC, Scerri T, Fanjul‐Fernandez M, Riseley JR, Gillies G, Pope K et al (2016) Familial cortical dysplasia caused by mutation in the mammalian target of rapamycin regulator NPRL3. Ann Neurol 79:132–137. PubMed

Strauss KA, Puffenberger EG, Huentelman MJ, Gottlieb S, Dobrin SE, Parod JM et al (2006) Recessive symptomatic focal epilepsy and mutant contactin‐associated protein‐like 2. N Engl J Med 354:1370–1377. PubMed

Weckhuysen S, Marsan E, Lambrecq V, Marchal C, Morin‐Brureau M, An‐Gourfinkel I et al (2016) Involvement of GATOR complex genes in familial focal epilepsies and focal cortical dysplasia. Epilepsia 57:994–1003. PubMed

Yoneda Y, Haginoya K, Kato M, Osaka H, Yokochi K, Arai H et al (2013) Phenotypic spectrum of COL4A1 mutations: porencephaly to schizencephaly. Ann Neurol 73:48–57. PubMed

A 5-year-old boy with super-refractory status epilepticus and RANBP2 variant warranting life-saving hemispherotomy

Cognitive performance in distinct groups of children undergoing epilepsy surgery-a single-centre experience